Inari Revenue and Competitors

Boston, MA USA

Location

#1762

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Inari's estimated annual revenue is currently $119.3M per year.(i)
  • Inari received $40.0M in venture funding in August 2018.
  • Inari's estimated revenue per employee is $217,000
  • Inari's total funding is $382M.
  • Inari's current valuation is $1.2B.

Employee Data

  • Inari has 550 Employees.(i)
  • Inari grew their employee count by 19% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$124.5M3697%N/AN/A
#2
$15.4M106-12%$29.5MN/A
#3
$31.3M23715%N/AN/A
#4
$39.5M276-1%N/AN/A
Add Company

Inari embraces diversity in every aspect of our business to drive innovation and help build a new food system. Our technology matches the complexity of nature to transform seed using predictive design and multiplex gene editing – unlocking the full potential through our SEEDesign™ platform. The result is step-change products that lead to more productive acres and a more sustainable future for the food system.

keywords:Agriculture, Technology

$382M

Total Funding

550

Number of Employees

$119.3M

Revenue (est)

19%

Employee Growth %

$1.2B

Valuation

N/A

Accelerator

Inari's People

NameTitleEmail/Phone
1
Information Technology Support AnalystReveal Email/Phone
2
Account Lead - EastReveal Email/Phone
3
Product Project ManagerReveal Email/Phone
4
Chief Product OfficerReveal Email/Phone
5
Director ComplianceReveal Email/Phone
6
Bioinformatics Functional Lead Science PlatformReveal Email/Phone
7
VP, Corporate AffairsReveal Email/Phone
8
Gene Delivery Team LeadReveal Email/Phone
9
Binformatics ScientistReveal Email/Phone
10
Senior Director RegulatoryReveal Email/Phone

Inari News

2022-04-20 - Inari Medical Joining S&P MidCap 400, Tri Pointe Homes to Join SmallCap 600

By Stephen Nakrosis. Shares of Inari Medical Inc. and Tri Pointe Homes Inc. are higher in Thursday's late-trading session, following news...

2022-04-20 - Inari Medical to Present at the Bank of America 2022 Healthcare Conference - Benzinga

("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous diseases,...

2022-04-19 - Inari Medical (NARI) Set to Announce Quarterly Earnings on ...

Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Inari Medical has set its FY 2022 guidance at EPS.

2021-05-12 - Inari Raises $208M in Series D Funding

Inari, a Cambridge, Mass.-based deveoper of a platform to enable yield increase, raised $208m in Series D funding. The round, which brought cumulative equity raised to more than $352m, was co-led by Flagship Pioneering with participation from Alexandria Venture Investments, Investment Corporati ...

2021-01-05 - Inari Expands Board of Directors with Appointment of Bob Bechek

CAMBRIDGE, Mass., Jan. 5, 2021 /PRNewswire/ -- Inari, a biotech seed company, today announced that Bob Bechek has been appointed to its board of directors. Bechek is a partner and former worldwide managing director (CEO) and board chair of consulting firm Bain & Company. His appointment, effe ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$85.7M55333%N/A
#2
$105.8M5648%N/A
#3
$180.9M5727%N/A
#4
$104.2M5756%N/A
#5
$236.7M590N/AN/A

Inari Funding

DateAmountRoundLead InvestorsReference
2018-08-10$40.0MBAcre Venture PartnersArticle